Boots Could Fetch ~$10B as Its Owner Weighs a Sale Over an IPO
Boots’ owner Sycamore is exploring a ~$10B sale of the UK chain over a London IPO; Australia’s Sigma Healthcare confirmed talks and the Weston family is also circling.
TL;DR — Boots’ owner Sycamore Partners is exploring a roughly $10 billion sale of the UK health-and-beauty chain over a planned London IPO, with Australia’s Sigma Healthcare confirming preliminary talks and the billionaire Weston family also circling.
One of the UK’s biggest health-and-beauty chains is in play. In June 2026, reports emerged that Boots’ owner is weighing a ~$10 billion sale.
The situation
Boots’ owner Sycamore Partners (which took Walgreens Boots Alliance private in 2025) is exploring a sale of the UK health-and-beauty chain valued at roughly $10 billion — a path that would scrap a planned London IPO. Named suitors include the billionaire Weston family and Australia’s Sigma Healthcare (ASX: SIG), which confirmed preliminary discussions; on the news, Sigma shares fell more than 5% to A$2.76, their lowest close since late April.
| Detail | |
|---|---|
| Potential value | ~$10B |
| Owner | Sycamore Partners |
| Suitors | Weston family; Sigma Healthcare |
| Alternative | A London IPO (would be scrapped) |
What they said
"Sigma continuously reviews opportunities that would create value for shareholders and has engaged in preliminary discussions in relation to the sale process." — Sigma Healthcare (ASX statement)
Why it matters
- Sale vs. IPO. The outcome decides whether Boots changes hands or lists publicly.
- Cross-border interest. An Australian pharmacy group bidding for a UK icon is notable.
- A retail bellwether. Boots’ fate is a read on UK health-and-beauty retail.
FAQ
Is Boots being sold?
Its owner, Sycamore Partners, is exploring a sale valued at roughly $10 billion as an alternative to a planned London IPO. Australia’s Sigma Healthcare confirmed preliminary talks (around June 9–10, 2026), and the billionaire Weston family is also reported as a suitor.
What would a sale mean for Boots’ planned IPO?
A trade sale at around $10 billion would scrap the planned London listing. The choice between a sale and an IPO is the central question for the UK health-and-beauty chain.
Sources
- Business of Fashion — Boots owner in talks on possible $10B sale
- Forbes Australia — Sigma Healthcare in talks to buy Boots
Image: Boots store, York by Malcolmxl5 — CC0, via Wikimedia Commons.
← Back to all posts